| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | +1.7% | -0.2% |
| Cost of Revenue | $1.7M | +4.0% | +2.0% |
| Gross Profit | $1.2M | -1.2% | -3.0% |
| R&D Expense | $7K | — | — |
| SG&A Expense | $2.0M | +3.5% | -5.3% |
| Operating Income | -$725K | -14.0% | +8.0% |
| Pre-tax Income | -$647K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $938K | — | -11.4% |
| Accounts Receivable | $839K | +11.4% | -6.2% |
| Inventory | $2.0M | +10.9% | +13.6% |
| Current Assets | $5.6M | +34.6% | +21.5% |
| Total Assets | $11.6M | +19.7% | +9.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | — |
| Investing Cash Flow | -$28K | — | — |
| Financing Cash Flow | $1.7M | — | — |
| +14.2% |
| Net Income | -$653K | +1.8% | +5.8% |
| EPS (Basic) | -$0.08 | +11.1% | +27.3% |
| EPS (Diluted) | -$0.08 | +11.1% | +27.3% |
| $3.3M |
| +38.1% |
| +8.5% |
| Long-term Debt | $614K | -3.8% | -13.4% |
| Total Liabilities | $6.0M | +29.8% | +8.2% |
| Stockholders' Equity | $5.2M | +11.0% | +10.6% |